F

FDC Ltd

Q4 FY16Pharmaceuticals & Biotechnology

FDC Q4 FY16 earnings call: Revenue & Margins

Q4 FY16 investor presentation: what the company reported on revenue, margins and projects.

Price₹346
Market cap₹5.7K Cr
P/E18.6
Updated25 Sept 2026
Read4 min read

Based on FDC Ltd's Q4 FY16 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.

The short version

Quarter Revenue (Q4 FY 2016 vs Q4 FY 2015): Total revenue about Rs. The presentation does not provide explicit EBITDA, operating margin, or profit after tax (PAT) figures for the quarter ended March 31, 2016, nor does it state year-on-year changes or explicit margin outlooks.

From FDC Ltd's Q4 FY16 earnings-call transcript · updated 25 Sept 2026.

Revenue & Sales Performance

  • Quarter Revenue (Q4 FY 2016 vs Q4 FY 2015): Total revenue about Rs. 845 Cr with about 11.4% primary internal sales growth noted for the full FY 2016; Q4 FY 2016 total revenue higher than Q4 FY 2015 (Rs. 760 Cr approx.), indicating positive growth.
  • Year-on-Year Growth: Secondary sales growth of 9.1% for FDC Limited in FY 2016; FDC ranked 25th with market share of 0.96%; Primary internal sales grew 11.4% Apr ’15 to Mar ‘16.
  • Volume data: No explicit volume figures reported in the presentation.
  • Outlook: No explicit forward-looking revenue or volume guidance is provided in the presentation; disclaimer notes uncertainties around forward-looking statements but no specific outlook is stated.

Profitability & Margins

See what FDC Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

The investor presentation provides limited direct details on capex, capacity expansion, or new plant projects. Based on the content: - **Manufacturing Setup:** The presentation lists multiple facilities: Roha, Waluj, Goa I & II, Goa III, Sinnar, BFS - Waluj, indicating a strong manufacturing base (Pages 5-6). - **No specific capex or investment amounts, project statuses, or timelines are explicitly stated.** - The presentation primarily focuses on financials, business segments, market performance, and contact details. Thus, no explicit information on capex, capacity expansion, new plants, or project timelines is provided in the available presentation content.

Top-ranked in Pharmaceuticals & Biotechnology

Ranked on what management guided this quarter

5x potential
Rev 1Mar 1
2Accretion Pha.
Rev 1Mar 2
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what FDC Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The investor presentation does not explicitly report any information regarding order book, order inflow, or pending orders. The presentation primarily covers: - Financial performance (Standalone and Consolidated Statements of Profit and Loss and Assets & Liabilities) - Regulatory affairs and approvals (page 17) - Business highlights including domestic and international sales, branded generic business, and therapy areas

2 more points management made on order book & pipeline

FDC Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹585 Cr, net profit ₹103 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were FDC Ltd Q4 FY16 results?

Quarter Revenue (Q4 FY 2016 vs Q4 FY 2015): Total revenue about Rs. The presentation does not provide explicit EBITDA, operating margin, or profit after tax (PAT) figures for the quarter ended March 31, 2016, nor does it state year-on-year changes or explicit margin outlooks.

What is FDC Ltd share price analysis?

FDC Ltd currently shows a neutral. The stock trades at a P/E of 18.6 with a market cap of ₹5,739 Cr. Investors should review the full earnings analysis for detailed insights.

Is FDC Ltd planning capital expenditure?

The investor presentation provides limited direct details on capex, capacity expansion, or new plant projects.

Keep FDC Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.